Ethanol exposure induces neurodegeneration in the developing central nervous system (CNS). Fetal alcohol spectrum disorders (FASD) are caused by ethanol exposure during pregnancy and are the most common nonhereditary cause of mental retardation. It is important to identify agents that provide neuroprotection against ethanol neurotoxicity. Multiple mechanisms have been proposed for ethanol-induced neurodegeneration, and oxidative stress is one of the most important mechanisms. Recent evidence indicates that glycogen synthase kinase 3b (GSK3b) is a potential mediator of ethanol-mediated neuronal death. Cyanidin-3-glucoside (C3G), a member of the anthocyanin family, is a potent natural antioxidant. Our previous study suggested that C3G inhibited GSK3b activity in neurons. Using a third trimester equivalent mouse model of ethanol exposure, we tested the hypothesis that C3G can ameliorate ethanol-induced neuronal death in the developing brain. Intraperitoneal injection of C3G reduced ethanol-meditated caspase-3 activation, neurodegeneration, and microglial activation in the cerebral cortex of 7-day-old mice. C3G blocked ethanol-mediated GSK3b activation by inducing phosphorylation at serine 9 while reducing the phosphorylation at tyrosine 216. C3G also inhibited ethanol-stimulated expression of malondialdehyde (MDA) and p47phox, indicating that C3G alleviated ethanol-induced oxidative stress. These results provide important insight into the therapeutic potential of C3G. V V C 2011 Wiley-Liss, Inc.
Fetal alcohol spectrum disorders (FASD) are caused by maternal alcohol consumption during pregnancy (Riley and McGee, 2005) . The most devastating consequences of fetal alcohol exposure are malformations of the central nervous system (CNS) and mental retardation. In experimental FASD models, ethanol exposure produces profound cognitive impairment and social behavior deficits in adult animals (Riley, 1990; Barbaccia et al., 2007) . Ethanol exposure disrupts a variety of developmental events; these include neurogenesis, neuron survival, cell migration, cell adhesion, axon outgrowth, synapse formation, and neurotransmitter function (Miller, 1993 (Miller, , 1996 Swanson et al., 1995; Luo and Miller, 1998; Minana et al., 2000; Yanni and Lindsley, 2000; Bearer, 2001; Ikonomidou et al., 2001; Olney, 2004; Goodlett et al., 2005; Soscia et al., 2006; Kumada et al., 2007; Hoffman et al., 2008) . These ethanolinduced structural and biochemical alterations in the brain may underlie many of the behavioral deficits observed in FASD. Despite attempts to increase public awareness of the risks involved, the number of women drinking during pregnancy in the United States has not declined (Ebrahim et al., 1999) . Therefore, it is important to develop strategies that can prevent or ameliorate alcohol-induced damages to the CNS.
Ethanol increases the production of reactive oxygen species (ROS) in the brain, and oxidative stress has been proposed as a potential mechanism for ethanol neurotoxicity (Goodlett and Horn, 2001; Chen and Luo, 2010) . Glycogen synthase kinase 3b (GSK3b), a serine/threonine kinase, is a key mediator of neuronal apoptosis. Recent studies suggest that GSK3b is a potential mediator of ethanol neurotoxicity (Luo, 2009) . We have isolated a natural antioxidant from blackberries, cyanidin-3-glucoside (C3G), which can scavenge ethanol-induced ROS and also effectively inhibit GSK3b activity in vitro (Ding et al., 2006; Chen et al., 2009) . C3G is a member the anthocyanin family and is present in various vegetables and fruits, especially edible berries. C3G offers neuroprotection against cerebral ischemia in a mouse model (Kang et al., 2006) . C3G and its metabolites protect neuronal cells against bamyloid peptide-and H 2 O 2 -induced mitochondria damage and DNA fragmentation in vitro (Tarozzi et al., 2007 (Tarozzi et al., , 2008 . We hypothesized that C3G may ameliorate ethanol-induced damage to the developing CNS. Rodent models of FASD have been used extensively to investigate the mechanisms of ethanol-induced damage to the CNS.
Administration of ethanol to rodents during the synaptogenesis period (also known as the brain growth spurt period), which occurs in early postnatal days, is equivalent to ethanol exposure during the third trimester of pregnancy in humans (Maier et al., 1999) . We used a well-established mouse model of developmental ethanol exposure in which ethanol was administered subcutaneously at a total dose of 5 g/kg to 7-day-old mice (Olney et al., 2002) . Acute ethanol exposure in this study models binge ethanol intake in humans. Previous studies demonstrated that ethanol exposure caused a widespread neuroapoptosis, which was accompanied by microglial activation (Saito et al., 2010) . We showed here that an intraperitoneal (ip) injection of C3G reduced ethanolmeditated neurodegeneration and microglial activation in the cerebral cortex. C3G also inhibited ethanol-induced GSK3b activation and oxidative stress.
MATERIALS AND METHODS Materials
Antiactive caspase-3, anti-GSK3b, antiphospho-GSK3b (Ser9), and antiphospho-GSK3b (Tyr216) antibodies were obtained from Cell Signaling (Beverly, MA). Anti-p47phox antibody was obtained from Santa Cruz Biotechnology (Santa Cruz, CA). Anti-ionized calcium-binding adaptor molecule-1 (Iba-1) antibody was obtained from Wako Pure Chemical Industries (Osaka, Japan). Fluoro-Jade C was a generous gift from Dr. Larry C. Schmued at the National Center for Toxicological Research/FDA (Jefferson, AR). Cyanidin-3-glucoside (C3G) was purified from blackberries using high-performance liquid chromatography as previously described (Ding et al., 2006) . The purity of C3G isolated by this method was 99%. Other chemicals and reagents were obtained from Sigma (St. Louis, MO).
Animals and Ethanol Exposure Paradigm
C57BL/6 mice were obtained from Harlan Laboratories (Indianapolis, IN) and maintained at the Animal Facility of the University of Kentucky Medical Center. All procedures were performed in accordance with the guidelines set by the NIH and the Animal Care and Use Committee of the University of Kentucky. An acute ethanol exposure paradigm, which had been shown to induce robust neurodegeneration in infant mice (Olney et al., 2002; Liu et al., 2009) , was employed. Seven-day-old mice (PD7) were injected subcutaneously with saline or ethanol (2.5 g/kg, 20% solution in saline) at two different times: time 0 and 2 hr. C3G (30 mg/kg or 10 mg/kg, 5 mg/ml in saline) was injected intraperitoneally 1 day before the first ethanol injection and again 30 min before the first ethanol injection. At specified times after the ethanol injection, the brain was removed and processed for immunoblotting or immunohistochemical analysis. For the study of C3G distribution in the brain, there were 10 animals (n 5 10). For the remaining studies, there were five animals for each treatment group (n 5 5).
Determination of C3G in Brain Tissues
Mice were injected intraperitoneally with C3G (30 mg/ kg). At specified times after the injection, mice were anesthetized by an intraperitoneal injection of chloral hydrate (350 mg/kg) and then perfused with ice-cold physiological saline to remove the blood. The whole brain was quickly excised and weighed, and the tissue samples were rapidly frozen in liquid nitrogen and kept at -808C. Brains were crushed in 1% HCl aqueous solution (0.1 g tissue/ml) and spiked with 50 ng/ml cyanidin 3,5-diglucoside as an internal standard. After centrifugation (3,500g, 10 min) at 48C, anthocyanins were purified with a Sep-Pak C 18 Vac solid-phase extraction cartridge (Waters, Milford, MA) and washed with 5% formic acid. C3G was eluted with methanol containing 5% formic acid. The eluent was carefully evaporated under N 2 flow at room temperature. The residue was dissolved in the mobile phase and applied to a LC-MS/MS system for analysis.
Preparation of Brain Tissue and Immunoblotting
After treatment, the mice were anesthetized by an intraperitoneal injection of ketamine (20 mg/kg)/xylazine (3 mg/ kg; Sigma-Aldrich, St. Louis, MO), and the brain was immediately dissected. The tissues were frozen in liquid nitrogen and stored at -808Ñ . Proteins were extracted as previously described (Wang et al., 2007) . Briefly, tissues were homogenized using an ice-cold lysis buffer containing 50 mM TrisHCl (pH 7.5), 150 mM NaCl, 1 mM EGTA, 1 mM PMSF, 0.5% NP-40, 0.25% SDS, 5 lg/ml leupeptin, and 5 lg/ml aprotinin. Homogenates were centrifuged at 20,000g for 30 min at 48Ñ , and the supernatant fraction was collected.
The immunoblotting procedure has been previously described (Chen at al., 2004) . Briefly, aliquots of the protein samples (30 lg) were separated on a SDS-polyacrylamide gel by electrophoresis. The separated proteins were transferred to nitrocellulose membranes. The membranes were blocked with either 5% BSA or 5% nonfat milk in 0.01 M PBS (pH 7.4) and 0.05% Tween-20 (TPBS) at room temperature for 1 hr. Subsequently, the membranes were probed with primary antibodies directed against target proteins overnight at 48C. After three quick washes in TPBS, the membranes were incubated with a secondary antibody conjugated to horseradish peroxidase (Amersham, Arlington Heights, IL). The immune complexes were detected by the enhanced chemiluminescence method (Amersham). In some cases, the blots were stripped and reprobed with either an antitubulin or an antiactin antibody. The density of immunoblotting was quantified with Quantity One software (Bio-Rad, Hercules, CA).
Fluoro-Jade C Staining
Fluoro-Jade C staining was performed as previously described (Schmued et al., 2005) . Briefly, brain sections were mounted onto gelatin-coated slides and dried overnight at room temperature. The slides were immersed in a solution of 1% sodium hydroxide and 80% ethanol for 5 min, then in 70% alcohol for 2 min, followed by 2 min in distilled water. Slides were transferred in 0.06% potassium permanganate solution for 10 min. After being rinsed in water for 2 min, slides were immersed in a solution of 0.1% acetic acid and 0.0001% Fluoro-Jade C for 10 min. Slides were washed three times in distillated water and dried. Fluoro-Jade C-positive cells were counted by using a previous method (Ke et al., 2003) . Briefly, five representative sections containing retrosplenial granular cortex and lateral parietal association cortex were photographed. For each section, Fluoro-Jade C-positive cells in/on right retrosplenial granular cortex were counted with stereo Investigator software (version 8; MicroBrightField, San Diego, CA). The mean of Fluoro-Jade C-positive cells in these sections was determined.
Immunohistochemistry
After treatments, the mice were deeply anesthetized with chloral hydrate (350 mg/kg), then perfused with saline, followed by 4% paraformaldehyde in 0.1 M potassium phosphate buffer (pH 7.2). The brains were removed and postfixed in 4% paraformaldehyde for an additional 24 hr and then transferred to 30% sucrose. The brain was sectioned at 40 lm with a sliding microtome (Leica Microsystems, Wetzlar, Germany).
The immunohistochemical staining for active caspase-3 and Iba-1 was performed as previously described (Liu et al., 2009) . Briefly, free-floating sections were incubated in 0.3% H 2 O 2 in methanol for 30 min at room temperature and then treated with 0.1% Triton X-100 for 10 min in PBS. The sections were washed with PBS three times and then blocked with 1% BSA and 0.01% Triton X-100 for 1 hr at room temperature. The sections were incubated with primary antibodies: anticleaved caspase-3 antibody (1:10,000) or anti-Iba-1 antibody (1:1,000) overnight at 48C. Negative controls were performed by omitting the primary antibody. After being Fig. 1 . Determination of C3G in the developing brain. Seven-day-old (PD7) mice received an intraperitoneal injection with C3G (30 mg/kg). At 15 min, 30, min, 1 hr, 2 hr, and 6 hr after C3G injection, the brain tissue was harvested and the concentration of C3G was determined with an LC-MS/MS system as described in Materials and Methods. Each data point is the mean 6 SEM of 10 animals. Fig. 2 . Effect of C3G on ethanol-induced caspase-3 activation in the developing brain. PD7 mice were pretreated with C3G (10 mg/kg) and injected with ethanol as described in Materials and Methods. At specified times after the first ethanol injection, the brain was removed and the expression of cleaved caspase-3 was examined with immunohistochemistry (IHC; A) or immunoblotting analysis (B). The immunoblotting analysis was replicated three times for each sample. Images were quantified and normalized to the expression of tubulin. Each data point is the mean 6 SEM of five animals. The value on the y axis is the fold increase over untreated controls (C). Scale bar 5 200 lm. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.] rinsed in PBS, sections were incubated with a biotinylated goat anti-rabbit IgG (Vector Laboratories, Burlingame, CA; 1:200) for 1 hr at room temperature. The sections were washed three times with PBS, then incubated in an avidin-biotin-peroxidase complex (Vector Laboratories; 1:100 in PBS) for 1 hr and developed in 0.05% 3,3 0 -diaminobenzidine (DAB; SigmaAldrich) containing 0.003% H 2 O 2 in PBS. The number of Iba-1-positive cells was determined using a method similar to that used for quantifying Fluoro-Jade C-positive cells.
Assessments of Brain Malondialdehyde Content
The malondialdehyde (MDA) levels in the brain tissue were determined with an MDA detection kit (Nanjing Jiancheng Bioengineering Institute), which is based on the measurement of the interaction between thiobarbituric acid (TBA) and MDA. The principle of the method is based on measuring absorbance of the pink color produced by the interaction of TBA with MDA at 532 nm. Briefly, mice were anesthetized by an intraperitoneal injection of chloral hydrate (350 mg/kg). The cerebral cortex was immediately dissected and homogenized on ice in 9 volumes of saline. The homogenates were centrifuged at 4,500g at 48C for 10 min. The protein concentration in the supernatants was determined using a BCA protein assay kit (Pierce, Rockford, IL). The MDA concentration in the supernatant was determined with a spectrophotometer at 532 nm and expressed as nanomoles per milligram protein according to the manufacturer's instructions.
Statistical Analysis
Differences among treatment groups were tested using ANOVA. Differences in which P was less than 0.05 were considered statistically significant. In cases in which significant Fig. 3 . Effect of C3G on ethanol-induced neurodegeneration in the cerebral cortex. PD7 mice were treated with C3G and ethanol as described above. At 8 hr after the first ethanol injection, the cerebral cortex was removed and sectioned. A: The degenerating neurons were detected with Fluoro-Jade C staining (green) as described in Materials and Methods. B: The number of Fluoro-Jade C-positive cells was determined as described in Materials and Methods. There were five animals for each treatment group. Asterisk denotes a statistically significant difference from ethanol-treated group. Scale bar 5 200 lm. differences were detected, specific post hoc comparisons between treatment groups were examined via Student-Newman-Keuls tests.
RESULTS

C3G Ameliorates Ethanol-Induced Neurodegeneration
The distribution of C3G in the brain was evident 15 min after intraperitoneal injection (Fig. 1) . The levels of C3G peaked 1 hr after administration (approximately 3.5 nmol/g). C3G was undetectable in the brain 6 hr following injection. Consistent with previously reported results (Olney et al., 2002; Liu et al., 2009) , the ethanol injection caused the cleavage of caspase-3 (activation of caspase-3; Fig. 2 ). Administration of C3G (10 mg/kg) significantly reduced the ethanol-mediated activation of caspase-3 (Fig. 2) , suggesting that it decreased ethanolinduced apoptosis. The effect of a higher C3G dosage (30 mg/kg) was similar to that of 10 mg/kg. Therefore, 10 mg/kg was used for all our experiments. In control animals, no Fluoro-Jade C-positive cell was detected. Ethanol exposure increased Fluoro-Jade C-positive cells in the cerebral cortex, which was indicative of neurodegeneration (Fig. 3) . On the other hand, C3G treatment diminished the number of Fluoro-Jade C-positive cells, suggesting that C3G decreased neurodegeneration caused by ethanol exposure. We next determined the effect of C3G on ethanol-mediated microglial activation. As shown in Figure 4 , the resting microglia displayed multiple thin processes and an elongated cell body, whereas active microglia had intensive Iba-1 immunostaining and a round cell body with retracted/thick processes (Fig. 4) . Ethanol activated microglia, and C3G treatment significantly reduced the amount of active microglia (Fig. 4) .
C3G Alleviates Ethanol-Induced GSK3b Activation and Oxidative Stress
Recent evidence indicated that GSK3b is a potential mediator of ethanol neurotoxicity and that excessive activation of GSK3b may result in neuronal death (Luo, 2009) . The activity of GSK3b is positively regulated by its phosphorylation at tyrosine 216 and negatively by the phosphorylation of serine 9 (Luo, 2009 ). C3G blocked ethanol-induced phosphorylation of GSK3b at tyrosine 216 and simultaneously enhanced the phosphorylation of serine 9, indicating that C3G inhibited ethanol-mediated activation of GSK3b (Fig. 5) . Furthermore, C3G blocked ethanol-induced MDA production, a product of lipid peroxidation (Fig. 6) . Our recent data indicate that NADPH oxidase plays a critical role in ethanol-induced reactive oxygen species (ROS) in the brain (manuscript in preparation). p47phox is an essential regulatory protein of NADPH oxidase (Takeya and Sumimoto, 2003) . Ethanol drastically increased the expression of p47phox. As shown in Figure 7 , ethanol caused an approximately 80-fold increase of p47phox in the developing brain, and C3G significantly reduced ethanol-induced p47phox up-regulation.
DISCUSSION
This study has demonstrated that C3G is able to ameliorate some of ethanol's neurotoxicity in the developing brain. C3G reduces ethanol-induced neurodegeneration and microglial activation in the brains of 7-dayold mice. It also inhibits ethanol-mediated activation of GSK3b and oxidative stress.
It has been previously demonstrated that some anthocyanins, including C3G, are able to cross the Fig. 5 . Effect of C3G on ethanol-mediated phosphorylation of GSK3b. PD7 mice were treated with C3G and ethanol as described above. At 8 hr after the first ethanol injection, the brain was removed and the expression of p-GSK3b (Ser9) was examined by IHC (A) and the expression of p-GSK3b (Tyr216) and p-GSK3b (Ser9) was also examined by immunoblotting analysis (B). The immunoblotting analysis was replicated three times for each sample. Images were quantified and normalized to the expression of actin.
Each data point is the mean 6 SEM of five animals. The value on the y axis is the fold increase over untreated controls (C). Asterisk denotes a statistically significant difference from untreated controls. Number sign denotes a significant difference from ethanol-treated groups. Scale bars 5 200 lm in top panels; 50 lm in bottom panels.
[Color figure can be viewed in the online issue, which is available at wileyonlinelibrary. com.] blood-brain barrier (BBB) and localize in various brain regions important for motor and learning and memory functions (Chen and Luo, 2010) . In a study in which rats were fed a blueberry supplement or a control diet for 8-10 weeks, several anthocyanins, including C3G, were found in the cerebellum, cortex, hippocampus, or striatum, but not in the controls (Andres-Lacueva et al., 2005) . In another study in which rats were fed a blackberry anthocyanin-enriched diet for 15 days, C3G was the predominant form of anthocyanin detected in the brain homogenate, and C3G content was higher in the brain than in the plasma (Talavéra et al., 2005) .
Our results confirm that C3G is quickly distributed in the brain after ip injection; the brain C3G concentration reaches approximately 3.5 nmol/g 1 hr after administration. Similarly, Marczylo et al. (2009) demonstrate that the peak levels of C3G are achieved in the liver, kidneys, lungs, heart, and prostate within 30 min after tail vein injection (1 mg/kg). The maximal concentrations of C3G in these organs ranged from 1 to 8 nmol/ g. We have previously shown that an injection of C3G to mice (ip, 9.5 mg/kg, three times/week) significantly inhibits A549 tumor xenograft growth and metastasis in mice (Ding et al., 2006) . Based on a simplistic approximation, the resulting concentration would be about 0.5 lM in the plasma and near 1 nmol/g in the lungs and prostate (Marczylo et al., 2009 ). This tissue concentration is less than one-tenth of the concentration shown to impair the growth and migration of A549 cells in vitro (Ding et al., 2006) . We have previously shown that C3G at 5 lM is able to reverse ethanol-induced inhibition of neuronal differentiation in culture . Therefore, the concentrations required for in vivo action of C3G could be lower than those used in vitro. We have not determined C3G concentration in the plasma. Compared with an anthocyanins-rich diet, administration of purified C3G may result in relatively higher C3G levels in the plasma. The estimated C3G in the plasma of mice would be about 0.5 lM. However, the administration of an anthocyanins-rich diet such as elderberry extract resulted in only 0.045 lM in human plasma (Prior and Wu, 2006) . C3G protection against ethanol-induced neuroapoptosis is evident by a decrease in caspase-3 activation and the number of Fluoro-Jade C-positive cells. Ethanol-induced neurodegeneration is accompanied by microglial activation, which may be a secondary response to ethanol-induced injury to the brain (Saito et al., 2010) . C3G inhibition of microglial activation may result Fig. 6 . Effect of C3G on ethanol-induced lipid peroxidation. PD7 mice were treated with C3G and ethanol as described above. At 8 hr after the first ethanol injection, the brain was removed and the concentration of MDA, a product of lipid peroxidation, was determined as described in Materials and Methods. Each data point is the mean 6 SEM of five animals. The reading on the y axis is a value relative to untreated controls. Asterisk denotes a statistically significant difference from all other groups. Fig. 7 . Effect of C3G on an ethanol-induced increase in p47phox. PD7 mice were treated with C3G and ethanol as described above. At 8 hr after the first ethanol injection, the brain was removed and the expression of p47phox was examined with immunoblotting analysis (A). The immunoblotting analysis was replicated three times for each sample. Images were quantified and normalized to the expression of actin. Each data point is the mean 6 SEM of five animals. The value on the y axis is the fold increase over untreated controls (B). Asterisk denotes a statistically significant difference from untreated controls. Number sign denotes a significant difference from ethanol-treated groups.
from an alleviation of neuronal damage. GSK3b has been identified as a potential mediator of ethanol neurotoxicity (Luo, 2009) . We have previously demonstrated that high expression/activity of GSK3b sensitizes neurons to ethanol-induced apoptosis and that inhibition of GSK3b offers protection against ethanol-induced death of cultured neuronal cells (Liu et al., 2009) ; lithium, an inhibitor of GSK3, reduces ethanol-mediated neuroapoptosis in the developing brain (Luo, 2010) . Full activity of GSK3b generally requires phosphorylation at tyrosine 216, and, conversely, phosphorylation at serine 9 inhibits GSK3b activity. In the brain, C3G enhances the phosphorylation at serine 9 and inhibits ethanolinduced phosphorylation at tyrosine 216. Therefore, it is likely that C3G's neuroprotection is mediated by its inhibition of GSK3b. C3G is an antioxidant and scavenges ethanolinduced ROS production in cultured neuronal cells . The current study confirms the antioxidant property of C3G in vivo by showing that it reduces ethanol-induced lipid peroxidation in the developing brain. Like us, Li et al. (2008) report that oral administration of C3G (4-8 mg/kg) significantly reduced ethanol-induced lipid peroxidation and free radicals in gastric tissues. Our recent results suggest that ethanolinduced ROS production in the developing brain is mediated mainly by the activation of NADPH oxidase through p47phox up-regulation (data not shown). We show here that C3G blocks ethanol-induced up-regulation of p47phox, suggesting that C3G may reduce ROS production by inhibiting the activation of NADPH oxidase.
C3G may underdo deglycosylation in vivo. We have not determined the levels of aglycone cyanidin in the brain. Tarozzi et al. (2007) demonstrated that aglycone cyanidin also offers protection against oxidative stress-induced neuronal damage in culture. It is unknown whether aglycone cyanidin contributes to neuroprotection by peripheral administration of C3G. We have previously shown that C3G offers protection against ethanol neurotoxicity in culture . Regardless of the contribution of aglycone cyanidin, the importance of our finding is in demonstrating that peripheral administration of C3G is sufficient to ameliorate ethanol-induced neurodegeneration.
C3G exhibits diverse beneficial health properties. For example, it displays chemopreventive and chemotherapeutic properties in various in vitro and animal models of carcinogenesis and tumor development (Chen et al., 2005 (Chen et al., , 2006 Shih et al., 2005; Zhang et al., 2005 Zhang et al., , 2008 Ding et al., 2006) . Other beneficial properties of C3G include antidiabetic (Sasaki et al., 2007) , antiinflammation (Kim and Park, 2006; Xia et al., 2006) , antiatherogenic (Xia et al., 2006) , and antiobesity (Tsuda et al., 2003) activities. C3G is a potent antioxidant and inhibits GSK3b . Our finding that C3G can protect neurons against ethanol toxicity not only provides an insight into the therapeutic potential of this anthocyanins but also help us to understand the mechanisms of ethanol-induced neurodegeneration.
